Breast Cancer Vaccines Look Promising (HealthDay via Yahoo! News)

THURSDAY, June 26 (HealthDay News) — Women with metastatic breast cancer who developed an immune response to an investigational vaccine lived twice as long as those who didn’t have an immune response, new research shows.

More: continued here

This entry was posted on Thursday, June 26th, 2008 and is filed under Measles. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Get a Trackback link

No Comments Yet - You can be the first to comment!